Trogenix: Funding, Investors & Team (Sep 2026)
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
Trogenix has raised $94.1M across 1 funding round on record, the most recent a Series A of $94.1M announced in Oct 2025.
That round is above the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Trogenix Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Trogenix Funding Rounds
Trogenix Founders and Leadership Team
Contact details for the Trogenix team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Trogenix Funding Compared to Other Biotechnology Startups
Trogenix's latest round of $94.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Trogenix in Biotechnology and Edinburgh
Companies Similar to Trogenix
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Trogenix Funding FAQs
What does Trogenix do?
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
How much funding has Trogenix raised?
Trogenix has raised $94.1M across 1 round on record. The most recent is a Series A of $94.1M announced in Oct 2025.
When did Trogenix last raise funding?
Trogenix's most recent funding round on record is a Series A of $94.1M, announced in Oct 2025.
Who founded Trogenix?
FundedIQ lists Steve Pollard (Founder) at Trogenix.
Who is the CEO of Trogenix?
Ken Macnamara is listed as CEO at Trogenix.
Where is Trogenix headquartered?
Trogenix is based in Edinburgh, United Kingdom.
How many employees does Trogenix have?
Trogenix is in the 1-10 employee band.
How does Trogenix's funding compare to other Biotechnology startups?
Trogenix's latest round of $94.1M is above the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Trogenix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Trogenix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.